Giant Cell Arteritis (GCA)
27 clinical trials · Condition
◉ Watch Giant Cell Arteritis (GCA)
| Record | Firm | Date |
|---|---|---|
| Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis (NCT05479448) | University Hospital, Basel, Switzerland | 2022-06-03 |
| Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment (NCT05193396) | Marianne Andersen | 2022-02-01 |
| Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA) (NCT04930094) | Novartis Pharmaceuticals | 2021-10-06 |
| A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis (NCT03725202) | AbbVie | 2019-01-24 |
| TArget Trial Emulation Comparing Effectiveness of Tocilizumab vs Methotrexate In Corticosteroid-Treated GCA Patients (NCT07459335) | Groupe français d'étude des Maladies Inflammatoires de loeil | 2012-01-01 |
Track Giant Cell Arteritis (GCA) automatically
Every clearance here is in the API, with alerts when new ones post.